Martin Gebel
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis.
Journal: European journal of heart failure
Published: February 23, 2024
A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry.
Journal: Therapeutic innovation & regulatory science
Published: November 13, 2023
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
Journal: Journal of the American College of Cardiology
Published: August 16, 2023
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
Journal: Clinical kidney journal
Published: September 20, 2022
Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study.
Journal: Vascular specialist international
Published: September 08, 2022
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: September 08, 2022
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Journal: Diabetes care
Published: February 11, 2022
Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 30, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Journal: Annals of internal medicine
Published: September 13, 2021
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
Journal: European heart journal
Published: August 27, 2021
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 31, 2021
Last Updated: 09/26/2026